Growth Investing

Many consumers are still ignoring the quickest way to lower their utility bills.  Swapping out all of your older light bulbs for new light-emitting diode (LED) bulbs can save hundreds of dollars in power costs. And the fact that these bulbs can last up to 25,000 hours means you’re all set for the next decade. This new technology has been a notable success story for Home Depot (NYSE: HD), and its key LED supplier, Cree (Nasdaq: CREE). You would think that Wal-Mart (NYSE: WMT) would also like to have been a major vendor of this cutting-edge, cost-saving lighting technology. But… Read More

Many consumers are still ignoring the quickest way to lower their utility bills.  Swapping out all of your older light bulbs for new light-emitting diode (LED) bulbs can save hundreds of dollars in power costs. And the fact that these bulbs can last up to 25,000 hours means you’re all set for the next decade. This new technology has been a notable success story for Home Depot (NYSE: HD), and its key LED supplier, Cree (Nasdaq: CREE). You would think that Wal-Mart (NYSE: WMT) would also like to have been a major vendor of this cutting-edge, cost-saving lighting technology. But the LEDs it sold from many manufacturers have always been a bit too pricey for Wal-Mart’s rank-and-file shoppers.  Yet Wal-Mart’s new house-brand line of LEDs changes everything.#-ad_banner-# Wal-Mart’s Great Value LED lights, made by privately held TCP Inc., are priced under $10, which is crucial in two respects. It’s a price point that lures many more consumers to make the change, considering these bulbs can now pay for themselves in terms of power consumption in just two or three years. And it’s a nightmare price point for Cree, which appears hard-pressed to make profits at such a price.  At least… Read More

The business of data is growing bigger and bigger. An astounding 2.5 quintillion bytes of data are created every day, cluttering computer systems around the globe. As more and more companies clamor to find space for the new, archive the old, and analyze it all so it… Read More

To say the Affordable Care Act (better known as Obamacare) has been controversial is an understatement. So, as investors, what should we make of the latest political brinkmanship? How about we make some money? Remember: No matter what the situation, there… Read More

Obamacare may be on the defunding chopping block, but not every health care stock out there depends on the success — or even the existence — of the Affordable Care Act.#-ad_banner-# A law enacted in 2009 called the Health Information Technology for Economic and Clinical Health Act… Read More

Identifying a great turnaround opportunity can be hugely profitable. When investors become universally negative about a company’s prospects, you’ve got the chance to spot early signs of improvement, and latch on before the crowd does.  Of course, it’s impossible to perfectly time a turnaround, even if your analysis is roughly… Read More

To say the Affordable Care Act (better known as Obamacare) has been controversial is an understatement. So, as investors, what should we make of the latest political brinkmanship? How about we make some money? Remember: No matter what the situation, there is always a bull market somewhere. Obamacare is no exception. Here’s how we’re going to profit: 32 million currently uninsured Americans could soon be insured through the Affordable Care Act. This, combined with an aging population, will be a boon to the pharmaceutical industry. Read More

To say the Affordable Care Act (better known as Obamacare) has been controversial is an understatement. So, as investors, what should we make of the latest political brinkmanship? How about we make some money? Remember: No matter what the situation, there is always a bull market somewhere. Obamacare is no exception. Here’s how we’re going to profit: 32 million currently uninsured Americans could soon be insured through the Affordable Care Act. This, combined with an aging population, will be a boon to the pharmaceutical industry. And I’d like to tell you about the best pure-play pharmacy benefit company on the market. Express Scripts (Nasdaq: ESRX) is the largest pharmacy benefit management (PBM) company in the U.S.#-ad_banner-# Put simply, PBMs operate as middlemen between drugmakers and employers. Express Scripts operates a mail-order pharmacy business as well as a network of retail pharmacies. The company also provides a service that processes prescription claims made by its clients’ members. In today’s age of shopping and doing business online, ESRX offers several unique services. The company offers… Read More

To say the Affordable Care Act (better known as Obamacare) has been controversial is an understatement. So, as investors, what should we make of the latest political brinkmanship? How about we make some money? Remember: No matter what the situation, there is always a bull market somewhere. Obamacare is no exception. Here’s how we’re going to profit: 32 million currently uninsured Americans could soon be insured through the Affordable Care Act. This, combined with an aging population, will be a boon to the pharmaceutical industry. Read More

To say the Affordable Care Act (better known as Obamacare) has been controversial is an understatement. So, as investors, what should we make of the latest political brinkmanship? How about we make some money? Remember: No matter what the situation, there is always a bull market somewhere. Obamacare is no exception. Here’s how we’re going to profit: 32 million currently uninsured Americans could soon be insured through the Affordable Care Act. This, combined with an aging population, will be a boon to the pharmaceutical industry. And I’d like to tell you about the best pure-play pharmacy benefit company on the market. Express Scripts (Nasdaq: ESRX) is the largest pharmacy benefit management (PBM) company in the U.S.#-ad_banner-# Put simply, PBMs operate as middlemen between drugmakers and employers. Express Scripts operates a mail-order pharmacy business as well as a network of retail pharmacies. The company also provides a service that processes prescription claims made by its clients’ members. In today’s age of shopping and doing business online, ESRX offers several unique services. The company offers… Read More

To say the Affordable Care Act (better known as Obamacare) has been controversial is an understatement. So, as investors, what should we make of the latest political brinkmanship? How about we make some money? Remember: No matter what the situation, there is always a bull market somewhere. Obamacare is no exception. Here’s how we’re going to profit: 32 million currently uninsured Americans could soon be insured through the Affordable Care Act. This, combined with an aging population, will be a boon to the pharmaceutical industry. Read More

To say the Affordable Care Act (better known as Obamacare) has been controversial is an understatement. So, as investors, what should we make of the latest political brinkmanship? How about we make some money? Remember: No matter what the situation, there is always a bull market somewhere. Obamacare is no exception. Here’s how we’re going to profit: 32 million currently uninsured Americans could soon be insured through the Affordable Care Act. This, combined with an aging population, will be a boon to the pharmaceutical industry. And I’d like to tell you about the best pure-play pharmacy benefit company on the market. Express Scripts (Nasdaq: ESRX) is the largest pharmacy benefit management (PBM) company in the U.S.#-ad_banner-# Put simply, PBMs operate as middlemen between drugmakers and employers. Express Scripts operates a mail-order pharmacy business as well as a network of retail pharmacies. The company also provides a service that processes prescription claims made by its clients’ members. In today’s age of shopping and doing business online, ESRX offers several unique services. The company offers… Read More